ISO 11070: Guidewire, Introducer and Dilator Requirements

Introduction

ISO 11070 is the standard that decides whether the cheapest devices in a catheter lab are tested as seriously as the most expensive ones. Guidewires, sheath introducers, dilators and introducer needles are bought by the box and opened by the dozen, and they are routinely treated as commodity accessories. The regulators do not treat them that way. Under the EU MDR a guidewire intended for the coronary arteries is a Class III device, and the FDA has a dedicated guidance on guidewire performance testing because coating separation from intravascular devices produced serious adverse events. The standard is short, its test methods are precise, and the files built on it are often thinner than the device risk justifies.

This guide is for the engineers and regulatory leads who have to turn ISO 11070 into evidence that survives a Notified Body review or a 510(k). It treats the standard as one input to a file that starts in the ISO 14971 risk management process and ends in the EU MDR technical documentation, because that is where accessory files fail: not on the bench, but in the link between the bench and the requirements.

We cover what the standard contains clause by clause, its edition and harmonisation status in 2026, the requirements for each of the five device types, kits, classification under the MDR, the tests reviewers expect beyond the standard, the FDA route, the mapping to the GSPR, and the six findings that recur.

Table of Contents

• What ISO 11070 covers and how it is organised
• Five devices, one purpose: getting a catheter into the vessel
• Clause 4: the requirements every accessory shares
• ISO 11070 edition and harmonisation status in 2026
• Introducer needles, introducer catheters and sheath introducers
• Introducer needles: point, hub and the strength of the union
• Introducer catheters: tip and tensile integrity
• Sheath introducers: two leakage tests and a haemostasis valve
• Guidewire requirements: where ISO 11070 is strictest
• Size designation and the safety wire
• Fracture, flexing and peak tensile force
• Dilators and kits: the clauses most files underestimate
• Why a guidewire can be Class III under the MDR
• The tests reviewers expect that ISO 11070 does not contain
• ISO 11070 in an FDA 510(k)
• Mapping ISO 11070 evidence to the GSPR
• Six findings that recur in accessory files
• Frequently asked questions
• Conclusions

What ISO 11070 covers and how it is organised

The full title of the standard is Sterile single-use intravascular introducers, dilators and guidewires. It is published by ISO/TC 84, the same committee that maintains the ISO 10555 series for intravascular catheters, and the two are designed to work together: ISO 10555-1 explicitly excludes catheter accessories from its scope and points to ISO 11070 for them. Where ISO 10555 covers the catheter that stays in the vessel, ISO 11070 covers the devices that get it there.

That relationship is the first thing a test plan has to get right. A sheath introducer is not tested to ISO 10555 because it looks like a short catheter, and a central venous catheter kit is not covered by ISO 11070 alone because it contains a guidewire. Each device in the kit is tested to the standard written for it, and the kit is then verified as a combination.

Five devices, one purpose: getting a catheter into the vessel

ISO 11070 specifies requirements for five device types supplied sterile and intended for single use in conjunction with intravascular catheters. Introducer needles puncture the skin and vessel wall and provide the first path into the lumen. Introducer catheters perform the same function with a flexible catheter placed over a needle. Sheath introducers create a working channel through which catheters and other devices are passed, usually with a haemostasis valve that limits blood loss. Guidewires are passed through the needle or sheath to guide the catheter to its position, and dilators enlarge the puncture so that a larger sheath or catheter can follow.

The common denominator is the intended use with an intravascular catheter. A guidewire used in the biliary tract, or a dilator used in a non-vascular access procedure, is outside the scope even if its design is identical. Where a manufacturer sells the same wire for vascular and non-vascular use, the intended purpose of each variant determines whether ISO 11070 applies, and the technical documentation should say so explicitly.

Clause 4: the requirements every accessory shares

Clause 4 applies to all five devices. It requires them to be sterile and biocompatible, to have surfaces free from extraneous matter and defects, to resist corrosion where metallic parts contact fluids, and to be radio-detectable where that property is claimed. It also sets general requirements for the information supplied by the manufacturer, which every device clause then supplements with its own labelling requirements.

As with ISO 10555, the evidence for sterility and biocompatibility does not come from the ISO 11070 laboratory. It comes from the sterilisation validation and from the biological evaluation under ISO 10993-1, which for a guidewire or sheath means blood contact and, where coatings are present, a careful look at the coating chemistry. The ISO 11070 report covers the physical and mechanical requirements; the file has to show where the rest is.

Clauses 5 to 9 add requirements for each device type, Clause 10 covers kits, and eight normative annexes from B to I describe the test methods. Annex A is informative and gives guidance on materials and design. The clause structure is worth knowing by heart, because it is how the GSPR checklist and the test reports should be cross-referenced.

ISO 11070 edition and harmonisation status in 2026

The current edition is ISO 11070:2014, the second edition, published in November 2014, together with Amendment 1 published in 2018. The second edition cancelled and replaced the first edition of 1998 and was technically revised; its introduction states two purposes, updating requirements and test methods to support the function of the guidewire, and updating size designation. ISO reviewed the standard again in 2025 and confirmed it, so the 2014 edition with its amendment remains current. The European adoption is EN ISO 11070:2014 with EN ISO 11070:2014/A1:2018, and national versions such as BS EN ISO 11070:2014+A1:2018 consolidate the two.

Under the MDR, ISO 11070 is not harmonised. It does not appear in Implementing Decision (EU) 2021/1182 as amended up to Decision (EU) 2026/1231, and the European versions are listed by national standards bodies with no associated directive or regulation. You can confirm the current list on the European Commission harmonised standards page for medical devices. The consequence is the same as for ISO 10555: applying the standard gives no presumption of conformity, and the file has to demonstrate that each relevant clause addresses the GSPR it is cited against.

ISO 11070 being "only" state of the art does not make it optional. It makes the argument your job. A GSPR checklist that cites EN ISO 11070:2014/A1:2018 with a clause-to-requirement mapping is stronger than one that claims a presumption the Official Journal does not grant.

Two adjacent standards behave differently and are often confused with it. EN ISO 23908:2025, on sharps injury protection mechanisms for single-use needles, introducers for catheters and needles used for blood sampling, is harmonised under the MDR since June 2026, so an introducer needle with a safety mechanism can rely on a presumption for that feature while its ISO 11070 performance still needs the state-of-the-art argument. ISO 80369-7, the standard for intravascular small-bore connectors that governs the hubs of most ISO 11070 devices, is not harmonised.

Introducer needles, introducer catheters and sheath introducers

Three of the five device clauses deal with devices that create access. They share a hub requirement and a size designation requirement, but each has its own failure modes, and the tests follow them.

Introducer needles: point, hub and the strength of the union

Clause 5 covers introducer needles. It requires a size designation, a needle point requirement, a hub, and the information to be supplied. Annex I gives the method for determining the strength of the union between the needle hub and the needle, which controls a hazard that is easy to overlook: a needle tube that separates from its hub during insertion or withdrawal. The test is simple, but it has to be performed on finished, sterilised devices, because adhesive bonds and crimped joints are exactly the features that sterilisation and ageing can weaken.

The needle point deserves more attention than the standard's brief clause suggests. Penetration force and point geometry drive both the clinical experience and the risk of vessel wall damage, and a reviewer comparing a new needle with an existing product will ask how the point was characterised. Visual inspection to the standard is the minimum; penetration force testing against a reference membrane is common practice for any needle that claims a performance advantage.

Introducer catheters: tip and tensile integrity

Clause 6 covers introducer catheters, the flexible catheters placed over a needle to gain access before a guidewire is passed. It adds requirements on the tip, peak tensile force tested by the Annex C method, the hub and size designation. The tip requirement exists because the transition from needle to catheter is where vessel trauma happens; a tip that is not smoothly tapered onto the needle catches on the vessel wall and can peel back. The tensile requirement protects against the catheter separating and leaving a fragment in the vessel.

Sheath introducers: two leakage tests and a haemostasis valve

Clause 7 is the most demanding of the access clauses. A sheath introducer must not leak from the sheath itself under pressure, tested by the Annex D method, and where it has a haemostasis valve, the valve must not leak beyond the specified limit, tested by the Annex E method. It also has requirements for the hub, peak tensile force by the Annex C method and size designation.

The haemostasis valve is the feature most often under-tested. The standard's leakage method verifies the valve at a point in time, but in clinical use the valve is opened and closed by every catheter, wire and device passed through it, sometimes dozens of times in a long procedure. A valve that passes the leakage test when new and leaks after twenty passes of a 6 French catheter is a design that met the standard and failed the patient. The risk analysis should drive a conditioning step before the leakage test, with the number and type of device passes justified by the intended use.

Size designation for sheaths has its own trap. A sheath is usually described by the size of the device it accepts rather than by its own outside diameter, which is the opposite of how most catheters are described, and the labelling has to make both clear enough that a clinician can match the sheath to the catheter and the puncture site. Inconsistent size descriptions between the label, the instructions for use and the test reports are one of the most common minor findings on sheath files.

Guidewire requirements: where ISO 11070 is strictest

Clause 8 carries the most detailed requirements in ISO 11070, and the 2014 revision was explicitly written to update the guidewire requirements and test methods. That focus is justified. A guidewire is a long, thin, often coated metal device navigated through tortuous anatomy, and its failure modes include fracture with an embolised fragment, unravelling of a coil, separation of a coating, and perforation of a vessel by a tip that is too stiff.

Size designation and the safety wire

The guidewire size designation covers the outside diameter and the length, and the 2014 edition updated the way size is designated. Guidewire diameter is still commonly expressed in inches in clinical practice, so a label that gives 0.035 in alongside the millimetre value is normal. What matters for conformity is that the designation follows the standard and is consistent everywhere it appears.

The safety wire requirement addresses coiled guidewire designs. In a spring-coil guidewire, a safety wire running inside the coil keeps the coil attached at both ends if it stretches or breaks, which is what prevents a fractured coil from separating and embolising. The clause sets requirements for that construction, and the design documentation should describe how the safety wire is attached and how the attachment is verified, because the joint is where the failure starts.

Fracture, flexing and peak tensile force

Three guidewire tests carry most of the weight. The fracture test of Annex F checks that the guidewire does not fracture when it is deformed in the way the method defines. The flexing test of Annex G bends the wire repeatedly to check that it resists damage, such as cracking or separation of the coil, under the kind of repeated deformation it sees during navigation. The peak tensile force test of Annex H checks the strength of the guidewire and its joints.

These tests are necessary and not sufficient. None of them measures how the wire behaves in the hands of an interventionalist: whether the tip deflects before it perforates, whether torque reaches the tip, whether the coating survives being drawn through a valve. Those characteristics come from FDA guidance and clinical practice, and they are covered later in this article.

Dilators and kits: the clauses most files underestimate

Clause 9 on dilators is the shortest device clause, with requirements for size designation, the hub and the information supplied, and the Annex C tensile method also covers dilators. Its brevity is misleading. A dilator is pushed through skin, subcutaneous tissue and vessel wall over a guidewire, and the clinically relevant questions are about the taper, the fit over the wire and the force needed to advance it. A dilator whose inside diameter is too large for the labelled wire can catch the wire and kink it; one whose taper is too abrupt raises the insertion force and the risk of vessel damage. These are design verification questions that the risk analysis has to raise, because the standard does not.

Clause 10 covers kits containing combinations of the devices specified in the standard, such as a sheath introducer supplied with a dilator, guidewire and introducer needle. This is where the regulatory analysis and the engineering analysis have to meet. From a testing standpoint, every component is tested to its own clause, and the combination is verified for compatibility: the guidewire passes through the needle, the dilator fits the wire and the sheath, and the sheath accepts the catheter sizes it is labelled for. A kit file that contains five separate component reports and no compatibility verification is incomplete.

From a regulatory standpoint, the question is what the kit is under the MDR. A manufacturer that designs and places the combination on the market under its own name as a single device carries out one conformity assessment for it, with the class set by the highest-risk component and its intended purpose. A combination of separately CE-marked devices put together by another party for a procedure is a system or procedure pack under Article 22, with its own statement and obligations. The technical documentation should state which situation applies, because the conformity route, the labelling and the UDI assignment all follow from that decision.

Why a guidewire can be Class III under the MDR

Classification is where the commodity view of accessories breaks down most visibly. Most ISO 11070 devices are surgically invasive and intended for transient use, meaning normally less than 60 minutes of continuous use, so they fall under Rule 6 of Annex VIII. Rule 6 places transient surgically invasive devices in Class IIa unless one of its indents applies, and two of those indents move devices to Class III: devices intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body, and devices intended specifically for use in direct contact with the heart, the central circulatory system or the central nervous system.

The central circulatory system is defined in Annex VIII as a specific list of vessels that includes the coronary arteries, the aorta, the pulmonary arteries, the carotid and cerebral arteries and the venae cavae. A guidewire intended to position catheters in the coronary arteries is therefore in direct contact with the central circulatory system by its intended purpose, and Class III follows. Manufacturers of coronary guidewires routinely declare them as Class III under Rule 6. The same wire labelled for peripheral vascular use only stays in Class IIa.

Duration can move a device to another rule. A sheath introducer left in place after a procedure, for example to allow repeat access or because the patient is anticoagulated, may be in continuous use for longer than an hour, which makes it short-term and brings Rule 7 into play. Rule 7 contains equivalent indents for direct contact with the heart, central circulatory system or central nervous system. In every case the classification follows the intended purpose as labelled, not the typical clinical use, and MDCG 2021-24, revised in April 2026, gives the examples and the reasoning a Notified Body will expect to see reflected in the classification rationale.

The class drives everything that follows: the conformity assessment route, the depth of the Notified Body review, the clinical evidence expectations in the clinical evaluation, and post-market obligations such as the periodic safety update report. A Class III guidewire file built on the assumption that it is a IIa accessory will be short of evidence in all of them at once.

The tests reviewers expect that ISO 11070 does not contain

ISO 11070 sets a floor. For guidewires and sheaths in particular, reviewers on both sides of the Atlantic expect a set of performance tests that the standard does not specify, most of them described in the FDA guidance on coronary, peripheral and neurovascular guidewires and in long-established practice. The way to justify which of them apply is the same as for any accessory: start from the hazard analysis and ask how each risk control is verified.

Particulate deserves a specific comment. Coated guidewires and sheaths can shed particles during use, and the evaluation of particulates associated with vascular devices is now an established expectation; AAMI TIR42 is the technical information report test laboratories and recent 510(k) summaries reference for it. The result has to be interpreted, not only reported: a particulate count means something only against an acceptance criterion derived from the risk analysis or from comparison with established devices.

Sample selection follows the same principles as for any intravascular device. Testing is performed on finished, sterilised devices, aged where a shelf life is claimed, and the worst-case configurations in the product family are identified with a written rationale. The smallest diameter guidewire is usually worst case for fracture and tensile strength, and the longest wire for torque transmission; a family file should show that reasoning rather than test every size or, worse, one size chosen for convenience.

Biological evaluation needs the same attention to the coating. A hydrophilic or hydrophobic coating is a material in its own right, with its own chemistry and its own potential to release substances or particles into the blood. The biocompatibility testing plan should treat the coated device as tested, with haemocompatibility under ISO 10993-4, rather than relying on data from the uncoated base wire.

ISO 11070 in an FDA 510(k)

Guidewires reach the US market under 21 CFR 870.1330, which classifies the catheter guide wire as a Class II device, and the 510(k) is the usual route. The central reference is the FDA final guidance Coronary, Peripheral, and Neurovascular Guidewires — Performance Tests and Recommended Labeling, issued in October 2019, which superseded a 1995 guidance and sets out FDA's recommendations for the device description, biocompatibility, sterility, shelf life, bench testing, animal and clinical testing where warranted, and labeling. It defines the three vascular territories precisely: the coronary vasculature includes the vessels within the heart, including the ostium of the left main coronary artery; the neurovasculature is typically the vasculature distal to the cervical segment of the internal carotid artery; and the peripheral vasculature is everything else.

A second guidance issued the same month, Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings — Labeling Considerations, applies to coated guidewires and sheaths and followed the FDA safety communication of November 2015 on lubricious coating separation. A coated guidewire submission that addresses ISO 11070 and the guidewire guidance but ignores the coating labeling recommendations is incomplete.

ISO 11070 test reports remain the backbone of the bench section. Recent 510(k) summaries for guidewires list dimensional inspection, tensile strength, fracture and flexing tests per ISO 11070 alongside particulate evaluation and the guidance-driven tests. Before declaring conformity, check the FDA Recognized Consensus Standards database for the recognition status and extent of recognition of the edition you cite, and remember that a declaration of conformity means conformity to all recognised parts, with any deviation identified and justified.

The FDA guidance and the MDR GSPR ask the same engineering questions in different words. Design one test programme that answers the guidance's bench recommendations and maps to the GSPR, and the US and EU files diverge only in format.

Mapping ISO 11070 evidence to the GSPR

Because ISO 11070 is not harmonised, each relevant clause has to be mapped to the requirement of Annex I it supports. The GSPR checklist entry should name the standard, the edition and the amendment, the clause, the test report and the conclusion, and it should be clear about which evidence comes from elsewhere.

In the technical documentation, the reports sit in Annex II Section 6 with a summary per test that states the standard, edition, samples, acceptance criteria, results and conclusion. The same results feed the risk management report and the clinical evaluation, and the three documents must cite the same reports and the same edition.

Six findings that recur in accessory files

Six problems account for most of the ISO 11070-related questions raised on introducer, dilator and guidewire files. As with catheters, none of them is about a device failing a test. They are about evidence that does not say what the manufacturer thinks it says.

An understated class is the most consequential, because it undermines every downstream section at once: a coronary or cerebral guidewire documented as Class IIa has the wrong conformity route, thin clinical evidence and the wrong post-market reporting cycle. Untested coating integrity comes next, because it is the failure mode the FDA singled out and the one the standard does not cover. The presumption-of-conformity claim, copied from a template written for a harmonised standard, is a factual error a reviewer can check in seconds.

Kits tested part by part, with five component reports and no compatibility verification, leave Clause 10 unaddressed. Haemostasis valves tested only when new ignore how the valve is used. Inconsistent size designations, mixing inches, millimetres and French sizes differently on the label, the instructions and the reports, look cosmetic but break the traceability between the device and its evidence.

Frequently asked questions

What is ISO 11070?

ISO 11070 is the international standard for sterile, single-use intravascular introducers, dilators and guidewires. It covers introducer needles, introducer catheters, sheath introducers, guidewires and dilators used with intravascular catheters, plus kits combining them. Clause 4 sets general requirements for all of them, Clauses 5 to 9 add device-specific requirements, and normative Annexes B to I give the test methods.

What is the current version of ISO 11070?

The current version is ISO 11070:2014, the second edition, with Amendment 1 published in 2018. ISO reviewed and confirmed it in 2025, so it remains current. The European adoption is EN ISO 11070:2014 with EN ISO 11070:2014/A1:2018, and national versions such as BS EN ISO 11070:2014+A1:2018 consolidate both documents.

Is ISO 11070 harmonised under the EU MDR?

No. EN ISO 11070 is not listed in Implementing Decision (EU) 2021/1182 as amended up to Decision (EU) 2026/1231, so applying it does not give a presumption of conformity with the MDR. It is still the generally acknowledged state of the art, and manufacturers should map each relevant clause to the GSPR it supports in the technical documentation.

What is the difference between ISO 11070 and ISO 10555?

ISO 10555 covers sterile, single-use intravascular catheters, the devices that remain in the vessel to deliver therapy or monitor. ISO 11070 covers the accessories used to place them: introducer needles, introducer catheters, sheath introducers, guidewires and dilators. ISO 10555-1 explicitly excludes these accessories and refers to ISO 11070, so a catheter kit is tested to both.

What tests does ISO 11070 require for guidewires?

Clause 8 requires a size designation, a safety wire requirement for the coil construction, a fracture test to Annex F, a flexing test to Annex G and a peak tensile force test to Annex H, plus labelling. Clause 4 adds surface, corrosion resistance and radio-detectability. Reviewers also expect tip flexibility, torque, coating integrity and particulate testing, which the standard does not cover.

Are guidewires Class III under the MDR?

It depends on the intended purpose. Under Rule 6 of MDR Annex VIII, transient surgically invasive devices are Class IIa unless intended specifically for direct contact with the heart, the central circulatory system or the central nervous system, in which case they are Class III. Coronary and cerebral guidewires are therefore Class III; guidewires labelled for peripheral use only are Class IIa.

Does the FDA require ISO 11070 for a guidewire 510(k)?

Conformity to a consensus standard is voluntary in a 510(k), but ISO 11070 test reports are the usual basis of the bench section for guidewires, which are Class II devices under 21 CFR 870.1330. The FDA guidance on coronary, peripheral and neurovascular guidewires issued in October 2019 adds the performance tests and labeling FDA expects beyond the standard.

Conclusions

ISO 11070 is a short standard with a long reach. It sets the test methods for five device types that every vascular procedure depends on, and its guidewire clauses are among the most specific in any device standard. What it does not do is classify the device, cover coatings, or replace the performance tests reviewers expect from FDA guidance and clinical practice. Those gaps have to be closed by the risk analysis and the test plan, and the result has to be mapped to the GSPR because the standard carries no presumption of conformity.

If you are building or remediating an accessory file, start with two decisions: the class under Rule 6 or Rule 7 for each labelled vascular territory, and the list of tests the hazard analysis requires beyond the standard. Everything else in the file follows from those two.

The Risk Management Documentation Kit on MD Regulatory includes the risk management plan, the ISO/TR 24971-based hazard analysis, design and use FMEAs and the GSPR checklist your ISO 11070 evidence has to trace through, and the EU MDR Technical Documentation Kit provides the Annex II structure the reports belong in — both immediately deployable in an existing ISO 13485 quality management system.

Related articles

• EU MDR Post-Market Surveillance
• ISO 13485 Design Controls